Strata Critical Medical (SRTA) Director Andrew Lauck Receives Award

What Happened Andrew Lauck, a director of Strata Critical Medical, was granted an award of 35,260 restricted stock units (RSUs) on 2026-07-30. The reported acquisition price is $0.00 (a compensation award rather than a market purchase). Per the filing, the RSUs will be settled in shares of the company's common stock upon vesting; 100% of the RSUs vest on the date of the Issuer’s 2027 Annual Meeting of Stockholders. The Form 4 was filed on 2026-08-03 (after the transaction date).

Key Details

• Transaction date: 2026-07-30; Transaction type/code: Award (A)
• Amount: 35,260 RSUs; Reported acquisition price: $0.00
• Vesting: 100% vests on the date of the 2027 Annual Meeting (per footnote F1)
• Shares owned after transaction: Not specified in the provided filing
• Filing: Reported on 2026-08-03 — appears filed later than the typical 2-business-day window for Form 4s

Context This was a granted equity award (RSUs), which is compensation and will convert to actual shares only upon vesting and settlement. Such awards do not represent an open-market purchase or sale at the time of grant and therefore should be interpreted as part of director compensation rather than an immediate bullish or bearish trade signal.